Ritedose and Newberry College Forge Strategic Partnership to Launch Pharmaceutical Manufacturing Program

COLUMBIA, S.C. Jan. 21, 2025 – In response to the growing demand for skilled professionals in South Carolina’s life sciences sector, The Ritedose Corporation has partnered with Newberry College to launch a new Pharmaceutical Manufacturing program, set to begin in the summer of 2025. This collaboration combines the strengths of both institutions to prepare students for careers in one of the state’s most dynamic industries.

Read More »

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

September 17, 2024 — The Ritedose Corporation, Inc. (Ritedose), the largest CDMO in the United States specializing in sterile Blow Fill Seal (BFS) production of unit dose solutions for the ophthalmic and respiratory markets, is proud to partner with Verona Pharma plc (Nasdaq: VRNA) as the development and manufacturing partner of Ohtuvayre, a new novel product for Chronic Obstructive Pulmonary Disease (COPD).

Read More »

Ritedose Pharmaceuticals Continues Tradition of Giving Back – Increases its Annual Donation to Unprecedented Amount of 1 Million Doses of Respiratory Medications to Dispensary of Hope for Low-income and Chronically lll Patients

COLUMBIA, S.C., August 12, 2024 – Ritedose Pharmaceuticals, a division of The Ritedose Corporation (Ritedose), the leading contract development and manufacturing organization (CDMO) specializing in sterile Blow Fill Seal (BFS) production, announces today that it will donate 1 Million (1M) doses to the national charitable medication distributor, Dispensary of Hope, to provide essential respiratory medications for low-income and chronically ill patients across the country.

Read More »

Ritedose Named Top 2023 Fundraiser by the American Heart Association

COLUMBIA, S.C. July 29, 2024 – Working together, The Ritedose Corporation (Ritedose) employees raised more than $77,000 during the company’s annual Field Day event this spring in support of the American Heart Association. Additionally, the Association recognized Ritedose as the #1 Field Day company in the nation for 2023.

Read More »

Ritedose Interns Volunteer for Food Distribution at State’s Largest Food Bank, Harvest Hope

COLUMBIA, S.C., July 12, 2024 – Eight interns from The Ritedose Corporation (Ritedose) volunteered at the Harvest Hope, South Carolina’s largest food distribution charity this month—packaging boxes of food for needy families on July 10. The humanitarian work was part of the Ritedose summer internship program, where student-employees volunteer for a day of community service.   

Read More »

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications

COLUMBIA, S.C. June 20, 2024 – The Ritedose Corporation (Ritedose), the leading contract development and manufacturing organization (CDMO) specializing in sterile Blow Fill Seal (BFS) production, announces a significant expansion of its production capabilities to meet the demand for ophthalmic and respiratory medications.

Read More »

Ritedose, South Carolina’s Leading Pharmaceutical Manufacturer, Buys 105 Acres of Land for Major Expansion.
50-percent growth in pharmaceutical manufacturing and sales spurs expansion, job creation

Columbia, S.C. (February 22, 2024) — The Ritedose Corporation (Ritedose) today announced a major expansion of its rapidly-growing pharmaceutical company with the recent purchase of 105 acres from the Midlands Technical College Enterprise Campus in Richland Northeast.

Read More »

Pioneers in aseptic production of sterile, single-dose medication